Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis
…, BD Michael, AS Winkler, E Beghi, A Guekht… - Neurology, 2021 - AAN Enterprises
Background and objectives One year after the onset of the coronavirus disease 2019 (COVID-19)
pandemic, we aimed to summarize the frequency of neurologic manifestations …
pandemic, we aimed to summarize the frequency of neurologic manifestations …
Action plan for stroke in Europe 2018–2030
…, M Dichgans, C Cordonnier, A Guekht… - European stroke …, 2018 - journals.sagepub.com
Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg meetings,
were convened to review the scientific evidence and the state of current services to identify …
were convened to review the scientific evidence and the state of current services to identify …
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
…, DM Needham, PR Williamson, A Guekht… - The Lancet …, 2022 - thelancet.com
Health consequences that persist beyond the acute infection phase of COVID-19, termed
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
…, S Avdeev, V Kapustina, A Guekht… - Clinical & …, 2021 - Wiley Online Library
Background The long‐term sequalae of COVID‐19 remain poorly characterized. We assessed
persistent symptoms in previously hospitalized patients with COVID‐19 and assessed …
persistent symptoms in previously hospitalized patients with COVID‐19 and assessed …
Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
Introduction We conducted a systematic review and meta‐analysis of the cognitive effects of
coronavirus disease 2019 (COVID‐19) in adults with no prior history of cognitive impairment…
coronavirus disease 2019 (COVID‐19) in adults with no prior history of cognitive impairment…
Post‐stroke cognitive decline: an update and perspectives for clinical research
…, Y Teuschl, E Richard, A Guekht… - European journal of …, 2015 - Wiley Online Library
The close relationship between stroke and dementia is an important health issue. Ischaemic
stroke can facilitate the onset of vascular dementia as well as aggravate pre‐existing …
stroke can facilitate the onset of vascular dementia as well as aggravate pre‐existing …
Neurological events reported after COVID‐19 vaccines: an analysis of vaccine adverse event reporting system
…, D Garcia‐Azorin, H Gezegen, A Guekht… - Annals of …, 2022 - Wiley Online Library
Objective To identify the rates of neurological events following administration of mRNA (Pfizer,
Moderna) or adenovirus vector (Janssen) vaccines in the US Methods We used publicly …
Moderna) or adenovirus vector (Janssen) vaccines in the US Methods We used publicly …
[HTML][HTML] Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in …
…, N Bulanov, S Avdeev, V Kapustina, A Guekht… - BMC medicine, 2022 - Springer
Background Previous studies assessing the prevalence of COVID-19 sequelae in adults
and children were performed in the absence of an agreed definition. We investigated …
and children were performed in the absence of an agreed definition. We investigated …
[HTML][HTML] Factors influencing on quality of life in people with epilepsy
AB Guekht, TV Mitrokhina, AV Lebedeva, FK Dzugaeva… - Seizure, 2007 - Elsevier
OBJECTIVES: To assess the influence of different factors on health-related QOL in adults with
epilepsy in Moscow, Russia. METHOD: We evaluated quality of life in 242 patients (98 de …
epilepsy in Moscow, Russia. METHOD: We evaluated quality of life in 242 patients (98 de …
Cerebrolysin and Recovery After Stroke (CARS) A randomized, placebo-controlled, double-blind, multicenter trial
…, VW Rahlfs, E Doppler, D Meier, H Moessler, A Guekht - Stroke, 2016 - Am Heart Assoc
Background and Purpose— The aim of this trial was to investigate whether stroke patients
who receive Cerebrolysin show improved motor function in the upper extremities at day 90 …
who receive Cerebrolysin show improved motor function in the upper extremities at day 90 …